The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Hormonal contraception and risk of venous thromboembolism: national follow-up study
Open accessAbstract
OBJECTIVE: To assess the risk of venous thrombosis in current users of different types of hormonal contraception, focusing on regimen, oestrogen dose, type of progestogen, and route of administration. DESIGN: National cohort study. SETTING: Denmark, 1995-2005. PARTICIPANTS: Danish women aged 15-49 with no history of cardiovascular or malignant disease. MAIN OUTCOME MEASURES: Adjusted rate ratios for all first time deep venous thrombosis, portal thrombosis, thrombosis of caval vein, thrombosis of renal vein, unspecified deep vein thrombosis, and pulmonary embolism during the study period. RESULTS: 10.4 million woman years were recorded, 3.3 million woman years in receipt of oral contraceptives. In total, 4213 venous thrombotic events were observed, 2045 in current users of oral contraceptives. The overall absolute risk of venous thrombosis per 10 000 woman years in non-users of oral contraceptives was 3.01 and in current users was 6.29. Compared with non-users of combined oral contraceptives the rate ratio of venous thrombembolism in current users decreased with duration of use (<1 year 4.17, 95% confidence interval 3.73 to 4.66, 1-4 years 2.98, 2.73 to 3.26, and >4 years 2.76, 2.53 to 3.02; P<0.001) and with decreasing dose of oestrogen. Compared with oral contraceptives containing levonorgestrel and with the same dose of oestrogen and length of use, the rate ratio for oral contraceptives with norethisterone was 0.98 (0.71 to 1.37), with norgestimate 1.19 (0.96 to 1.47), with desogestrel 1.82 (1.49 to 2.22), with gestodene 1.86 (1.59 to 2.18), with drospirenone 1.64 (1.27 to 2.10), and with cyproterone 1.88 (1.47 to 2.42). Compared with non-users of oral contraceptives, the rate ratio for venous thromboembolism in users of progestogen only oral contraceptives with levonorgestrel or norethisterone was 0.59 (0.33 to 1.03) or with 75 mug desogestrel was 1.12 (0.36 to 3.49), and for hormone releasing intrauterine devices was 0.90 (0.64 to 1.26). CONCLUSION: The risk of venous thrombosis in current users of combined oral contraceptives decreases with duration of use and decreasing oestrogen dose. For the same dose of oestrogen and the same length of use, oral contraceptives with desogestrel, gestodene, or drospirenone were associated with a significantly higher risk of venous thrombosis than oral contraceptives with levonorgestrel. Progestogen only pills and hormone releasing intrauterine devices were not associated with any increased risk of venous thrombosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“COCs also increase low-grade inflammation, alter lipid metabolism and affect the coagulation system, resulting in an increased risk for thromboembolic events”
From Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial (2023) · cites this paper as Lidegaard et al., 2009
In the citing paper
“It is also well known that COCs increase the risk of thromboembolic events (Sitruk-Ware et al., 2007a; Lidegaard et al., 2009, 2012; de Bastos et al., 2014).”
From Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial (2023) · cites this paper as Lidegaard et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jick, H., Jick, S. S., Myers, M. W., Vasilakis‐Scaramozza, C., & Gurewich, V. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91928-7 · Cited by 721
Spitzer, W. O., Lewis, M. A., Heinemann, L. A. J., Thorogood, M., & MacRae, K. D. (1996) · BMJ · doi:10.1136/bmj.312.7023.83 · Cited by 590
Bloemenkamp, K. W. M., Helmerhorst, F. M., Rosendaal, F. R., Vandenbroucke, J. P., & Buller, H. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91929-5 · Cited by 576
Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 472
Poulter, N. R., Cl, C., Farley, T., Meirik, O., & Marmot, M. G. (1995) · PubMed · Cited by 404
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 332
Population-based study of risk of venous thromboembolism associated with various oral contraceptives
Farmer, R., Lawrenson, R., Thompson, C., Kennedy, J., & Hambleton, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07496-x · Cited by 329
Farley, T., Meirik, O., Cl, C., Marmot, M. G., & Poulter, N. R. (1995) · PubMed · Cited by 319
(1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(96)89711-6 · Cited by 259
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 712
Harada, T., & Momoeda, M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.051 · Cited by 22
Abnormal Uterine Bleeding in Young Women with Blood Disorders
Dickerson, K. E., Menon, N., & Zia, A. N. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.02.008 · Cited by 22
Pedersen, M. H., Wahlsten, L. R., Grønborg, H., Gislason, G., Petersen, M. M., & Bonde, A. N. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546519876054 · Cited by 22
Puberty in the Female and Its Disorders
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00016-6 · Cited by 23
Sueta, D., Akahoshi, R., Okamura, Y., Kojima, S., Ikemoto, T., Yamamoto, E., Izumiya, Y., Tsujita, K., Kaikita, K., Katabuchi, H., et al. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.7785 · Cited by 22
Combined oral contraceptives: venous thrombosis
de Bastos, M., Stegeman, B. H., Rosendaal, F. R., Vlieg, A. V. H., Helmerhorst, F. M., Stijnen, T., & Dekkers, O. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010813 · Cited by 22
Estrogen and thrombosis: controversies and common sense
DeLoughery, T. G. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9178-0 · Cited by 21
Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women
Kluft, C., Krug, A. H., Winkler, U. H., Jespersen, J., Gram, J., & Sidelmann, J. J. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-10-0748 · Cited by 21
Ramlakhan, K. P., Ahmed, I., Johnson, M. R., & Roos‐Hesselink, J. W. (2020) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2020.100049 · Cited by 22
Fabunmi, O. A., Dludla, P. V., & Nkambule, B. B. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1127104 · Cited by 21
Overview and assessment of risk factors for pulmonary embolism
Hoo, G. W. S. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/ers.13.7 · Cited by 21
Enfermedad tromboembólica pulmonar. Manejo clínico de la enfermedad aguda y crónica
Torbicki, A. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70186-x · Cited by 22
Hormone therapy and ovarian borderline tumors: a national cohort study
Mørch, L. S., Løkkegaard, E., Andreasen, A. H., Kjær, S. K., & Lidegaard, Ø. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9860-2 · Cited by 21
Winkler, U. H., Röhm, P., & Höschen, K. (2010) · Contraception · doi:10.1016/j.contraception.2009.12.005 · Cited by 21
ROYER, P. A., & Jones, K. P. (2014) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000072 · Cited by 20
Munro, M. G. (2013) · The Permanente Journal · doi:10.7812/tpp/13-018 · Cited by 20
Guidance on medical eligibility criteria for contraceptive use: identification of research gaps
Folger, S. G., Curtis, K. M., Tepper, N. K., Gaffield, M. E., & Marchbanks, P. A. (2010) · Contraception · doi:10.1016/j.contraception.2010.02.015 · Cited by 20
Briggs, P., Praet, C. A., Humphreys, S., & Zhao, C. (2013) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2012-100376 · Cited by 20
Kangasniemi, M. H., Arffman, R. K., Joenväärä, S., Haverinen, A., Luiro, K., Tohmola, T., Renkonen, R., Heikinheimo, O., Tapanainen, J. S., & Piltonen, T. T. (2023) · Human Reproduction · doi:10.1093/humrep/deac250 · Cited by 19
DeSancho, M. T., Dorff, T. B., & Rand, J. H. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e32833b2b84 · Cited by 19
Natural history of deep vein thrombosis in children
Spentzouris, G., Gasparis, A. P., Scriven, R. J., Lee, T., & Labropoulos, N. (2014) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355514536154 · Cited by 19
Ribeiro, D. D., Lijfering, W. M., Rosendaal, F. R., & Cannegieter, S. C. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13371 · Cited by 19
Vernon, E., Hiedemann, B. G., & Bowie, B. H. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0318-x · Cited by 19
Hou, R., Leathersich, A. M., & Ruud, B. T. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-310 · Cited by 19
Migraine with aura and increased risk of ischaemic stroke
Loder, E. (2009) · BMJ · doi:10.1136/bmj.b4380 · Cited by 19
Risk of venous thromboembolism in women with endometriosis
Wiegers, H. M. G., Scheres, L. J. J., Tahir, L., Hutten, B. A., Middeldorp, S., & Mijatovic, V. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.07.014 · Cited by 18
A New Contraceptive Pill Containing 17β-Estradiol and Nomegestrol Acetate
Christin‐Maître, S., Laroche, E., & Bricaire, L. (2012) · Women s Health · doi:10.2217/whe.12.70 · Cited by 18
Lackie, E., & Fairchild, A. L. (2016) · Contraception · doi:10.1016/j.contraception.2016.06.009 · Cited by 18
Petersen, J. F., Bergholt, T., Nielsen, A. K., Paidas, M. J., & Løkkegaard, E. C. L. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-09-0797 · Cited by 18
Larivée, N., Suissa, S., Khosrow‐Khavar, F., Tagalakis, V., & Filion, K. B. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14623 · Cited by 17
Impact of puberty, sex determinants and chronic inflammation on cardiovascular risk in young people
Allalou, A., Peng, J., Robinson, G., Marruganti, C., D’Aiuto, F., Butler, G. E., Jury, E. C., & Ciurtin, C. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1191119 · Cited by 19
Safety of hormonal contraception for obese women
Rocha, A. L. L., Campos, R. R., Miranda, M. M. S., Raspante, L. B. D. P., Carneiro, M. M., Vieira, C. S., & dos Reis, F. M. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1389893 · Cited by 17
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?
Reda, S., Morimont, L., Douxfils, J., & Rühl, H. (2020) · Hämostaseologie · doi:10.1055/a-1153-5824 · Cited by 17
Reproductive issues in women on direct oral anticoagulants
Beyer‐Westendorf, J., & Marten, S. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12512 · Cited by 17
The ESHRE Capri Workshop Group, Baird, D. T., Evers, J. L. H., Gemzell‐Danielsson, K., Glasier, A. F., Killick, S. R., Look, P. F. A. V., Vercellini, P., Yıldız, B. O., Benagiano, G., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms021 · Cited by 17
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17
Daniele, S. G., Kim, S. R., Grada, A. A., Moore, A. Y., Suozzi, K. C., & Bunick, C. G. (2022) · American Journal of Clinical Dermatology · doi:10.1007/s40257-022-00746-4 · Cited by 16
Significant Risks of Oral Contraceptives (OCPs)
Peck, R., & Norris, C. W. (2012) · The Linacre Quarterly · doi:10.1179/002436312803571447 · Cited by 16
Past oral contraceptive use and self-reported high blood pressure in postmenopausal women
Chiu, C. L., & Lind, J. M. (2015) · BMC Public Health · doi:10.1186/s12889-015-1392-3 · Cited by 16
Use of Hormone Replacement in Females with Endocrine Disorders
Christin‐Maître, S. (2017) · Hormone Research in Paediatrics · doi:10.1159/000457125 · Cited by 16
Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation
Maroo, A. P., & Chahine, J. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0392-x · Cited by 16
Consensus on the investigation of thrombophilia in women and clinical management
Nascimento, C. M. D. B., Machado, A. M. N., Guerra, J. C. D. C., Zlotnik, E., Campêlo, D. H. C., Kauffman, P., Waksman, H., Wolosker, N., Podgaec, S., & Hamerschlak, N. (2019) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2019ae4510 · Cited by 16
Hormones and thrombosis: risk across the reproductive years and beyond
Machin, N., & Ragni, M. V. (2020) · Translational research · doi:10.1016/j.trsl.2020.06.011 · Cited by 19
Baetta, R., Pontremoli, M., Martínez, A. E., Spickett, C. M., & Banfi, C. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.03.017 · Cited by 16
Mendoza, N., & Sánchez‐Borrego, R. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.02.017 · Cited by 16
Ellis, H. B., Sabatino, M. J., Clarke, Z., Dennis, G. S., Fletcher, A. L., Wyatt, C. W., Zia, A. N., & Wilson, P. L. (2019) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-18-00390 · Cited by 16
Jackson, E. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70010-x · Cited by 15
Risk of venous thromboembolism with oral contraceptives
Solymoss, S. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.111614 · Cited by 15
Nomegestrol acetate-17b-estradiol for oral contraception
Burke, A. E. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s39371 · Cited by 15
Raps, M., Curvers, J., Helmerhorst, F. M., Ballieux, B. E. P. B., Rosing, J., Thomassen, S., Rosendaal, F. R., & van Vliet, H. A. A. M. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2013.12.041 · Cited by 15
Heinemann, K., & Heinemann, L. A. J. (2011) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2011-14524 · Cited by 15
Dunne, C., Malyuk, D., & Firoz, T. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34454-1 · Cited by 15
Non-contraceptive applications of the levonorgestrel intrauterine system
Darney, P. D., & Rodriguez, M. I. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s6344 · Cited by 15
Larivée, N., Suissa, S., Coulombe, J., Tagalakis, V., & Filion, K. B. (2017) · Drug Safety · doi:10.1007/s40264-017-0525-2 · Cited by 15
Pulmonary Thromboembolic Disease. Clinical Management of Acute and Chronic Disease
Torbicki, A. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70168-7 · Cited by 15
Oral contraceptives and venous thromboembolism
Dunn, N. R. (2009) · BMJ · doi:10.1136/bmj.b3164 · Cited by 15
Oral hormonal contraceptives and cardiovascular risks in females
Bhullar, S. K., Rabinovich-Nikitin, I., & Kirshenbaum, L. A. (2024) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0041 · Cited by 15
Contraception and the obese woman
Reifsnider, E., Mendias, N., Davila, Y., & Babendure, J. B. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1111/1745-7599.12011 · Cited by 14
Allahabadi, S., Faust, M., & Swarup, I. (2021) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0000000000001798 · Cited by 14
Drospirenone enhances GPIb‐IX‐V‐mediated platelet activation
Fan, X., Chen, X., Wang, C., Dai, J., Lu, Y., Wang, K., Liu, J., Zhang, J., & Wu, X. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13109 · Cited by 14
Do women aged over 40 need different counseling on combined hormonal contraception?
Mendoza, N., Soto, E., & Sánchez‐Borrego, R. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.02.008 · Cited by 14
Injectable Vaginal Hydrogels as a Multi-Drug Carrier for Contraception
Nie, L., Zou, P., Dong, J., Sun, M., Ding, P., Han, Y., Ji, C., Zhou, Q., Yuan, H., & Suo, J. (2019) · Applied Sciences · doi:10.3390/app9081638 · Cited by 14
Mishell, J., & Shoupe, D. (2015) · Springer eBooks · doi:10.1007/978-3-319-20185-6 · Cited by 14
Advances in contraception: new options for postpartum women
Taub, R., & Jensen, J. T. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1316370 · Cited by 14
Rabe, T., Luxembourg, B., Ludwig, M. Z., Dinger, J. C., Bauersachs, R. M., Rott, H., Ao, M., & Albring, C. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 14
Liu, D., Song, D., Ning, W., Guo, Y., Lei, T., Qu, Y., Zhang, M., Gu, C., Wang, H., Ji, J., et al. (2023) · Cancers · doi:10.3390/cancers15225483 · Cited by 13
Sliwa, K. S., Rakisheva, A., Viljoen, C. A., Pfeffer, T. J., Simpson, M., Jackson, A. M., Petrie, M. C., van der Meer, P., Farhan, H. A., Jovanova, S., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3377 · Cited by 14
Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical Pharmacology
Lello, S., & Cavani, A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/102184 · Cited by 13
Lefevre-Scelles, A., Jeanmaire, P., Freund, Y., Joly, L., Phillipon, A.-L., & Roussel, M. (2020) · European Journal of Emergency Medicine · doi:10.1097/mej.0000000000000680 · Cited by 13
Abdulrehman, J., Elbaz, C., Aziz, D. J., Parpia, S., Fazelzad, R., Eischer, L., Rodger, M. A., Cannegieter, S. C., ten Cate‐Hoek, A. J., Nagler, M., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18331 · Cited by 13
Oral Contraceptives and Venous Thromboembolism: Pill Scares and Public Health
Reid, R. L. (2011) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)35084-8 · Cited by 13
The future of women's contraception: stakes and modalities
Hugon‐Rodin, J., Chabbert‐Buffet, N., & Bouchard, P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05688.x · Cited by 13
Reproductive and contraceptive issues in chronically ill adolescents
Bacopoulou, F., Greydanus, D. E., & Chrousos, G. P. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.532252 · Cited by 13
Landersoe, S. K., Petersen, K. B., Vassard, D., Larsen, E. C., Nielsen, H. S., Pinborg, A. B., Nøhr, B., Andersen, A. N., & Schmidt, L. (2019) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2019.1639659 · Cited by 13
Estrogen activates endothelial exocytosis
Kim, C. S. K., Yea, K., Morrell, C. N., Jeong, Y., & Lowenstein, C. J. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.019 · Cited by 13
Woman's contraceptive needs and preferences in the postpartum period: an I talian study
Giacomo, P. D., Sbarlati, A., Bagnasco, A., & Sasso, L. (2013) · Journal of Clinical Nursing · doi:10.1111/jocn.12432 · Cited by 13
Compagni, A., Melegaro, A., & Tarricone, R. (2013) · Value in Health · doi:10.1016/j.jval.2013.05.003 · Cited by 14
Sugiura, K., Ojima, T., Urano, T., & Kobayashi, T. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13706 · Cited by 13
The risk of deep venous thrombosis with oral contraceptives containing drospirenone
Dunn, N. (2011) · BMJ · doi:10.1136/bmj.d2519 · Cited by 13
Combined Oral Contraceptives and the Risk of Thrombosis
Khizroeva, J. K., Bitsadze, V. O., Sukhikh, G. T., Tretyakova, M. V., Gris, J., Elalamy, I., Gerotziafas, G., Левановна, К. Д., Kvaratskheliia, M., Tatarintseva, А. Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211010 · Cited by 12
Stegeman, B. H., Vos, H. L., Helmerhorst, F. M., Rosendaal, F. R., Reitsma, P. H., & Vlieg, A. V. H. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.05.019 · Cited by 12
Eick, C., Klinger-König, J., Zylla, S., Hannemann, A., Budde, K., Henning, A., Pietzner, M., Nauck, M. A., Völzke, H., Grabe, H. J., et al. (2021) · Metabolites · doi:10.3390/metabo11040193 · Cited by 12
A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents
Woods, G. M., Kerlin, B. A., O’Brien, S. H., & Bonny, A. E. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.05.007 · Cited by 12
Bala, N. S., Stanek, J. R., Vesely, S. K., Cronin, R. M., Creary, S. E., Roe, A. H., Xu, W., & O’Brien, S. H. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010204 · Cited by 12
Braga, G. C., Brito, M. B., Ferriani, R. A., de Oliveira, L. C. O., Garcia, A. A., Pintão, M. C., & Vieira, C. S. (2013) · Contraception · doi:10.1016/j.contraception.2013.06.012 · Cited by 12
Sidelmann, J. J., Skouby, S. O., Kluft, C., Winkler, U. H., Vitzthum, F., Schwarz, H., Gram, J., & Jespersen, J. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.06.013 · Cited by 12
Contraceptive needs of the adolescent
Steyn, P. S., & Goldstuck, N. D. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.012 · Cited by 12
Pharmacovigilance Working Party (PhVWP)
Wharf, C., London, E., O’Malley, K., & Terrace, E. (2011) · Cited by 12
Hasegawa, S., Matsui, T., Hane, Y., Abe, J., Hatahira, H., Motooka, Y., Sasaoka, S., Fukuda, A., Naganuma, M., Hirade, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182045 · Cited by 12
Alalami, H., Sathyapalan, T., & Atkin, S. L. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818805674 · Cited by 12
Pearls and Myths in the Evaluation of Patients with Suspected Acute Pulmonary Embolism
Stüssi‐Helbling, M., Arrigo, M., & Huber, L. C. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.01.011 · Cited by 12
Sugiura, K., Kobayashi, T., & Ojima, T. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14452 · Cited by 12
Women’s health in The BMJ : a data science history
Hamulyák, E. N., Brockmeier, A. J., Killas, J. D., Ananiadou, S., Middeldorp, S., & Leroi, A. M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039759 · Cited by 12
Bonnet, C., Blondel, B., & Moreau, C. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01255-y · Cited by 12
Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis.
Saadatnia, M., Naghavi, N., Fatehi, F., Zare, M., & Tajmirriahi, M. (2012) · Europe PMC (PubMed Central) · Cited by 12
Miyoshi, T., Oku, H., Asahara, S., Okamoto, A., Kokame, K., Nakai, M., Nishimura, K., Otsuka, F., Higashiyama, A., Yoshimatsu, J., et al. (2019) · International Journal of Hematology · doi:10.1007/s12185-019-02633-x · Cited by 12
Cirillo, F., Spinelli, A., Talia, M., Scordamaglia, D., Santolla, M. F., Grande, F., Rizzuti, B., Maggiolini, M., Gérard, C., & Lappano, R. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05269-6 · Cited by 11
Use of the Levonorgestrel Intrauterine Device in Women With Type 2 Diabetes
Lang, B., Josephy, T., Micks, E., McCoy, E., & Prager, S. (2018) · Clinical Diabetes · doi:10.2337/cd17-0028 · Cited by 11
Huang, Q., Chai, X., Xiao, C., & Cao, X. (2019) · Medicine · doi:10.1097/md.0000000000016440 · Cited by 11
Combined Oral Contraceptives and Vascular Thrombosis: A Single-Center Experience
Alsheef, M. A., Abuzied, Y., Alzahrani, G. R., AlAraj, N., AlAqeel, N., Aljishi, H., Alomar, M., Zaidi, A. R. Z., & Alarfaj, O. (2022) · Cureus · doi:10.7759/cureus.25865 · Cited by 11
Metadata
- Authors
- Lidegaard, O., Lokkegaard, E., Svendsen, A. L., & Agger, C.
- Affiliations
- University of Copenhagen (DK)
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2009-08-13
- Volume
- 339
- Issue
- aug13 2
- Pages
- b2890-b2890
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC2726928
- OpenAlex
- W2027062965
- Cited by
- 709
- References
- 29
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 17 · 2023: 27 · 2022: 35 · 2021: 42 · 2020: 33 · 2019: 31 · 2018: 34 · 2017: 46 · 2016: 32 · 2015: 41 · 2014: 61 · 2013: 74 · 2012: 45
- FWCI
- 44.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Rigshospitalet
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- hormonal contraception, venous thromboembolism, deep vein thrombosis, pulmonary embolism, oral contraceptives, estrogen dose, progestogens, levonorgestrel, norethisterone, desogestrel, gestodene, drospirenone, cyproterone, route of administration, duration of use, thrombosis risk
- MeSH terms
- Adolescent, Adult, Contraceptives, Oral, Combined, Contraceptives, Oral, Hormonal, Denmark, Epidemiologic Methods, Female, Humans, Middle Aged, Age Distribution, Venous Thromboembolism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review